These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22762556)

  • 1. Modification of decoy oligodeoxynucleotides to achieve the stability and therapeutic efficacy.
    Osako MK; Nakagami H; Morishita R
    Curr Top Med Chem; 2012; 12(15):1603-7. PubMed ID: 22762556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligonucleotide decoy to NF-kappaB slowly released from PLGA microspheres reduces chronic inflammation in rat.
    De Stefano D; De Rosa G; Maiuri MC; Ungaro F; Quaglia F; Iuvone T; Cinelli MP; La Rotonda MI; Carnuccio R
    Pharmacol Res; 2009 Jul; 60(1):33-40. PubMed ID: 19427583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral nuclear factor-κB decoy oligonucleotides delivery system with chitosan modified poly(D,L-lactide-co-glycolide) nanospheres for inflammatory bowel disease.
    Tahara K; Samura S; Tsuji K; Yamamoto H; Tsukada Y; Bando Y; Tsujimoto H; Morishita R; Kawashima Y
    Biomaterials; 2011 Jan; 32(3):870-8. PubMed ID: 20934748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in nuclease resistance and incorporation of NF-kappaB decoy oligodeoxynucleotides by modification of the 3'-terminus.
    Osako MK; Tomita N; Nakagami H; Kunugiza Y; Yoshino M; Yuyama K; Tomita T; Yoshikawa H; Ogihara T; Morishita R
    J Gene Med; 2007 Sep; 9(9):812-9. PubMed ID: 17640082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced intracellular uptake and inhibition of NF-kappaB activation by decoy oligonucleotide released from PLGA microspheres.
    De Rosa G; Maiuri MC; Ungaro F; De Stefano D; Quaglia F; La Rotonda MI; Carnuccio R
    J Gene Med; 2005 Jun; 7(6):771-81. PubMed ID: 15702489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional regulation of NF-kappaB by ring type decoy oligodeoxynucleotide in an animal model of nephropathy.
    Kim KH; Lee ES; Cha SH; Park JH; Park JS; Chang YC; Park KK
    Exp Mol Pathol; 2009 Apr; 86(2):114-20. PubMed ID: 19118545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled release of NFkappaB decoy oligonucleotides from biodegradable polymer microparticles.
    Zhu X; Lu L; Currier BL; Windebank AJ; Yaszemski MJ
    Biomaterials; 2002 Jul; 23(13):2683-92. PubMed ID: 12059017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic administration of ribbon-type decoy oligodeoxynucleotide against nuclear factor κB and ets prevents abdominal aortic aneurysm in rat model.
    Miyake T; Aoki M; Osako MK; Shimamura M; Nakagami H; Morishita R
    Mol Ther; 2011 Jan; 19(1):181-7. PubMed ID: 20877343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of NFkappaB decoy oligonucleotides released from biodegradable polymer microparticles on a glioblastoma cell line.
    Gill JS; Zhu X; Moore MJ; Lu L; Yaszemski MJ; Windebank AJ
    Biomaterials; 2002 Jul; 23(13):2773-81. PubMed ID: 12059028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF-κB Decoy ODN-Loaded Poly(Lactic-co-glycolic Acid) Nanospheres Inhibit Alveolar Ridge Resorption.
    Huang AC; Ishida Y; Li K; Rintanalert D; Hatano-Sato K; Oishi S; Hosomichi J; Usumi-Fujita R; Yamaguchi H; Tsujimoto H; Sasai A; Ochi A; Watanabe H; Ono T
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A decoy oligonucleotide to NF-κB delivered through inhalable particles prevents LPS-induced rat airway inflammation.
    De Stefano D; Coletta C; Bianca Rd; Falcone L; d'Angelo I; Ungaro F; Quaglia F; Carnuccio R; Sorrentino R
    Am J Respir Cell Mol Biol; 2013 Aug; 49(2):288-95. PubMed ID: 23590300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained polymeric delivery of gene silencing antisense ODNs, siRNA, DNAzymes and ribozymes: in vitro and in vivo studies.
    Khan A; Benboubetra M; Sayyed PZ; Ng KW; Fox S; Beck G; Benter IF; Akhtar S
    J Drug Target; 2004 Jul; 12(6):393-404. PubMed ID: 15545089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transfection of nuclear factor-kappaB decoy oligodeoxynucleotides prevents ischemic acute renal failure in rats].
    Cao CC; Ding XQ; Ou ZL; Liu CF; Li P; Wang L; Zhu CF
    Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(18):1597-602. PubMed ID: 14642117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear factor-kappaB decoy oligodeoxynucleotides prevent acute lung injury in mice with cecal ligation and puncture-induced sepsis.
    Matsuda N; Hattori Y; Jesmin S; Gando S
    Mol Pharmacol; 2005 Apr; 67(4):1018-25. PubMed ID: 15576632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfection of nuclear factor-kappaB decoy oligodeoxynucleotide protects against ischemia/reperfusion injury in a rat epigastric flap model.
    Uemura T; Tsujii M; Akeda K; Iino T; Satonaka H; Hasegawa M; Sudo A
    J Gene Med; 2012 Nov; 14(11):623-31. PubMed ID: 23080520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effect of ribbon-type nuclear factor-κB decoy oligonucleotides in a rat model of inflammatory bowel disease.
    Ozaki K; Makino H; Aoki M; Miyake T; Yasumasa N; Osako MK; Nakagami H; Rakugi H; Morishita R
    Curr Gene Ther; 2012 Dec; 12(6):484-92. PubMed ID: 23061565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice.
    Kawamura I; Morishita R; Tsujimoto S; Manda T; Tomoi M; Tomita N; Goto T; Ogihara T; Kaneda Y
    Gene Ther; 2001 Jun; 8(12):905-12. PubMed ID: 11426330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo transfection of NF-kappaB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats.
    Cao CC; Ding XQ; Ou ZL; Liu CF; Li P; Wang L; Zhu CF
    Kidney Int; 2004 Mar; 65(3):834-45. PubMed ID: 14871403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral injection of oligonucleotides to the NF kappa B binding site inhibits cachexia in a mouse tumor model.
    Kawamura I; Morishita R; Tomita N; Lacey E; Aketa M; Tsujimoto S; Manda T; Tomoi M; Kida I; Higaki J; Kaneda Y; Shimomura K; Ogihara T
    Gene Ther; 1999 Jan; 6(1):91-7. PubMed ID: 10341880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of decoy oligodeoxynucleotides-based approach to renal diseases.
    Tomita N; Azuma H; Kaneda Y; Ogihara T; Morishita R
    Curr Drug Targets; 2004 Nov; 5(8):717-33. PubMed ID: 15578952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.